US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renaissance Technologies Holdings

1,961.05

+10.680.55%

Number of Gainers:79

Number of Losers:15

Number of Flat:2

PE:- -

High:1,962.42

Open:1,950.49

Low:1,945.01

Close:1,950.37

Loading ...

AMD Announces New $6 Billion Share Repurchase Authorization

Amd Announces New $6 Billion Share Repurchase Authorization

THOMSON REUTERS

BUZZ-Gold miners fall as easing US-China tensions dim bullion's safe-haven appeal

Exelixis Shares up 4.4% Premarket After Q1 Revenue Beat

THOMSON REUTERS

CBOE Global Markets Inc. : Morgan Stanley Cuts to Underweight From Overweight

THOMSON REUTERS

Super Micro Computer Stock Extends Gains. What's Behind the Server Maker's Surge. -- Barrons.com

Incyte, Novartis Pharma Reach Settlement Over Jakafi Royalties

Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills -- Update

Target Corp. : Oppenheimer Cuts Target Price to $130 From $150

THOMSON REUTERS

Incyte Corp - to Pay Novartis $280 Mln in Royalty Settlement - SEC Filing

THOMSON REUTERS

Incyte: on May 11, Co & Novartis Entered Into Settlement Agreement With Respect to Litigation Initiated by Novartis

THOMSON REUTERS

Incyte Corporation Settles Royalty Dispute with Novartis, Agrees to $280 Million Payment and Reduced Future Royalties

BRIEF-Pony AI Announces Voluntary Extended Lock-Ups By Founders

Global-e, Shopify Extend Strategic Partnership With New Agreement

MT Newswires Live

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Novo Nordisk, Septerna to Collaborate on Oral Small Molecule Obesity Medicines

MT Newswires Live

Zoom 1Q Loss Y181.00M Vs Loss Y78.00M

Pony AI Inc. Announces Voluntary Extended Lock-Ups by Founders

THOMSON REUTERS

Novo Nordisk, Septerna to Partner on Oral Small Molecule Obesity Medicine

MT Newswires Live

Exelixis Inc : Stifel Raises Target Price to $38 From $36

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4532/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4532","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"Renaissance Technologies Holdings","latestPrice":1961.0458,"timestamp":1747425599999,"preClose":1950.37,"halted":0,"volume":1035340663,"delay":0,"changeRate":0.005474,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":10.675781,"latestTime":"05-16 16:00:00 EDT","open":1950.4907,"high":1962.4225,"low":1945.0125,"amount":144777388989.20688,"amplitude":0.008927,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.52351,"peRate":28.8574,"turnoverRate":0.008156,"increases":78,"decrements":16,"flats":1,"marketCap":21794949732672,"floatMarketCap":20385842244736},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1962.4225,"amplitude":0.008927,"preClose":1950.37,"low":1945.0125,"pbRate":"8.52351","latestPrice":1961.0458,"volume":1035340663,"delay":0,"open":1950.4907,"prevYearClose":2026.1482,"prevWeekClose":1842.5564,"prevMonthClose":1815.0321,"prevQuarterClose":1820.2863,"fiveDayClose":1842.5564,"twentyDayClose":1709.4374,"sixtyDayClose":2062.4106,"secType":"PLATE","market":"US","turnoverRate":0.008156,"peRate":28.8574,"marketCap":21794949732672,"floatMarketCap":20385842244736,"timestamp":1747425599999,"nameCN":"Renaissance Technologies Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":79,"down":15,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535102493","title":"AMD Announces New $6 Billion Share Repurchase Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2535102493","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535102493?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:00","pubTimestamp":1747227614,"startTime":"0","endTime":"0","summary":"SANTA CLARA, Calif., May 14, 2025  -- AMD  announced that its board of directors has approved a new $6 billion share repurchase program. This new authorization adds to the remaining balance of approximately $4 billion from its existing share repurchase program, increasing the total current repurchase authority to approximately $10 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AMD - Advanced Micro Devices Inc. published the original content used to generate this news brief via GlobeNewswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1bf4ea3a348b5c26f9213b92224d1aa0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL8FPnJk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0642271901.SGD","IE00B64PRP62.GBP","BK4554","BK4532","BK4534","LU0081259029.USD","BK4573","LU1951198990.SGD","LU0719512351.SGD","LU0127658192.USD","LU0109392836.USD","LU1242518931.SGD","BK4605","LU2360106780.USD","IE00B5949003.HKD","LU0889565833.HKD","LU1803068979.SGD","LU1880398471.USD","LU2458330169.SGD","IE0009356076.USD","LU0979878070.USD","LU1316542783.SGD","BK4512","BK4614","LU0823421333.USD","IE00BKPKM429.USD","LU1242518857.USD","LU1923623000.USD","LU2458330243.SGD","IE00BMPRXR70.SGD","BK4588","IE0004445239.USD","BK4575","AMD","BK4141","LU2264538146.SGD","LU0390134368.USD","BK4112","LU1989764664.SGD","LU1303367103.USD","LU0823434583.USD","IE00BGHQF748.EUR","LU1852331112.SGD","BK4566","LU0056508442.USD","LU1880398554.USD","NDAQ","BK4543","LU1988902786.USD","LU0082616367.USD"],"gpt_icon":1},{"id":"2535024971","title":"Amd Announces New $6 Billion Share Repurchase Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2535024971","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535024971?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:00","pubTimestamp":1747227600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"faa7ab872ee8caf59b3e74c50ca94186","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA51DTPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BMPRXR70.SGD","IE00B5949003.HKD","BK4575","LU1064131342.USD","LU2054465674.USD","LU0390134368.USD","BK4534","IE0004445239.USD","LU0082616367.USD","LU0979878070.USD","BK4554","LU0823434740.USD","BK4529","LU0081259029.USD","LU0889565833.HKD","BK4532","LU0056508442.USD","LU0823434583.USD","LU0823421416.USD","BK4573","LU0198837287.USD","LU1803068979.SGD","LU1242518931.SGD","LU2264538146.SGD","LU2250418816.HKD","BK4585","BK4605","LU1242518857.USD","BK4543","IE0009356076.USD","AMD","BK4566","LU1303367103.USD","LU2360106780.USD","LU1988902786.USD","LU0719512351.SGD","BK4588","LU1951198990.SGD","BK4141","LU1951200564.SGD","LU0642271901.SGD","BK4614","LU0109392836.USD","LU0127658192.USD","IE00BMPRXN33.USD","BK4612","BK4512","LU0823421333.USD","LU1852331112.SGD","LU1989764664.SGD"],"gpt_icon":0},{"id":"2535215210","title":"BUZZ-Gold miners fall as easing US-China tensions dim bullion's safe-haven appeal","url":"https://stock-news.laohu8.com/highlight/detail?id=2535215210","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535215210?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:43","pubTimestamp":1747226632,"startTime":"0","endTime":"0","summary":"BUZZ-Gold miners fall as easing US-China tensions dim bullion's safe-haven appeal** U.S.-listed shares of gold miners fall premarket, tracking a drop in prices of the precious metal GOL/** Spot gold XAU= down 1% at $3,214.33 per ounce, as easing U.S.-China trade tensions soothed fears of a potential global recession, boosting investors' appetite for risk and weighing on bullion's safe-haven appeal** Top miners Newmont NEM.N and Barrick Mining B.N both fall 0.8%** South African miners Sibanye Stillwater SBSW.N and Gold Fields GFI.N down about 1.2%, Harmony Gold HMY.N drops 2.2%** Canadian miners Kinross Gold KGC.N and Agnico Eagle Mines AEM.N fall 1.3% and 1%, respectively","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4N3RM14K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456854461.SGD","LU1223082519.USD","LU0345780281.USD","LU0496367417.USD","LU1223082196.USD","LU0498741114.HKD","LU0278409577.USD","LU2498475776.HKD","BK4585","LU0788109121.HKD","BK4533","LU1223083913.SGD","LU0055631609.USD","LU0612318971.USD","LU1430597077.USD","LU1883866441.USD","LU0075056555.USD","LU1023059493.AUD","LU0345780521.USD","BK4017","BK4532","LU0498741890.SGD","LU0266512127.USD","LU0368265764.SGD","LU0330918003.SGD","BK4588","LU0300736492.USD","NEM","LU0788108826.HKD","LU0640476718.USD","LU0612318385.USD","LU0300736062.USD","LU1280957306.USD","LU0654597011.USD","SG9999001143.SGD","LU0724618789.USD","BK4570","LU2462611646.USD"],"gpt_icon":0},{"id":"2535021528","title":"Exelixis Shares up 4.4% Premarket After Q1 Revenue Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2535021528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535021528?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:43","pubTimestamp":1747226626,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4N3RM154:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4532","EXEL"],"gpt_icon":0},{"id":"2535215480","title":"CBOE Global Markets Inc. : Morgan Stanley  Cuts to Underweight From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2535215480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535215480?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:43","pubTimestamp":1747226601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nAZN3TY2B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBOE","BK4112","BK4585","BK4532","BK4588"],"gpt_icon":0},{"id":"2535029221","title":"Super Micro Computer Stock Extends Gains. What's Behind the Server Maker's Surge. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2535029221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535029221?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:31","pubTimestamp":1747225860,"startTime":"0","endTime":"0","summary":"Shares of Super Micro Computer extended the previous day's gains in premarket trading Wednesday following a flood of good news.The stock surged 18% to $45.88. Futures tracking the S&P 500 and Nasdaq Composite, which were up 0.1% and 0.3%, respectively.Super Micro's steep ascent began Tuesday after Raymond James analysts initiated coverage at Outperform with a $41 price target. The firm dubbed the server maker \"a market leader in AI-optimized infrastructure\" and lauded its ability to offer \"competitive pricing\" relative to peers.Also on Tuesday, Super Micro said it had shipped a number of high-density servers powered by Advanced Micro Devices' EPYC 4005 series processors, and separately announced a $20 billion deal with Saudi Arabian data center company DataVolt.The multi-year partnership is meant to accelerate the delivery of GPU platforms and rack systems for DataVolt's hyperscale campuses, the companies said.An adverse opinion indicates that a company's financial statements are misre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"7e1b25fdd03aca39010f2816ba1718ad","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4512","MKR.USD.HKCC","BK4534","LU1242518931.SGD","IE00BMPRXR70.SGD","BK4566","BK4588","LU1852331112.SGD","LU2098885051.SGD","LU0719512351.SGD","LU1064131342.USD","LU1923623000.USD","IE00B5949003.HKD","SMCI","LU1880398471.USD","IE00BMPRXN33.USD","IE0004445239.USD","LU0109392836.USD","MKR.USD.CC","BK4612","BK4141","LU0889565833.HKD","LU0823434583.USD","LU1303367103.USD","LU1951200564.SGD","BK4614","LU2458330243.SGD","BK4554","LU0642271901.SGD","LU0979878070.USD","LU0198837287.USD","LU1316542783.SGD","LU1989764664.SGD","LU2250418816.HKD","LU1242518857.USD","BK4170","LU0823434740.USD","BK4573","LU2054465674.USD","LU0823421333.USD","LU1951198990.SGD","LU2360106780.USD","LU1880398554.USD","BK4532","LU0390134368.USD","BK4529","LU0127658192.USD","BK4575","LU0081259029.USD"],"gpt_icon":1},{"id":"2535292220","title":"Incyte, Novartis Pharma Reach Settlement Over Jakafi Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2535292220","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535292220?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:30","pubTimestamp":1747225800,"startTime":"0","endTime":"0","summary":"Incyte and Novartis Pharma reached a settlement related to litigation initiated by the latter company regarding royalty payments.Incyte said it agreed to pay Novartis $280 million to settle the disputed royalties on U.S. sales of blood-cancer treatment Jakafi through Dec. 31. The parties also agreed to reduce by 50% the royalty rate payable by the company to Novartis on future sales of Jakafi in the U.S. beginning Jan. 1, 2025.Incyte said the difference of $242.2 million between the total accrued royalties and the total amount it will pay to Novartis will be recorded in its financial statements for the quarter ending June 30.Incyte and Novartis entered into a collaboration and license agreement in 2009.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4585","BK4588","IE0002141913.USD","LU0070302665.USD","LU0208291251.USD","BK4578","IE00B4R5TH58.HKD","BK4550","LU0211331839.USD","IE00BFTCPJ56.SGD","INCY","BK4007","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4139","IE0009355771.USD","NVS","IE00BJJMRZ35.SGD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2535029878","title":"Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535029878","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535029878?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:24","pubTimestamp":1747225440,"startTime":"0","endTime":"0","summary":"Danish pharmaceutical giant Novo Nordisk and U.S. biotech Septerna agreed to collaborate on the development of pills to treat obesity, type 2 diabetes and other metabolic conditions.Under the terms of the agreement, Septerna is eligible to receive around $2.2 billion from Novo Nordisk, including more than $200 million in upfront and near-term milestone payments.The U.S. company will also receive research, development and commercial milestone payments, on top of tiered royalties on global net sales of marketed products. Novo Nordisk will cover all research-and-development costs.In premarket trading, Septerna shares were up 69%, while Novo Nordisk shares were up 1.2% in  afternoon European trading.Blockbuster obesity drugs currently on the market from Novo Nordisk and Eli Lilly both work by targeting GPCRs. In Novo Nordisk's case, its Wegovy treatment targets a GPCR known as GLP-1, while Lilly's Zepbound targets both GLP-1 and GIP.Novo Nordisk and Septerna will seek to discover, develop ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","BK4007","LU1093756168.USD","BK4599","NVO","SEPN","LU1093756325.SGD","LU0154236417.USD","IE00BKVL7J92.USD","BK4585","BK4532","BK4588"],"gpt_icon":1},{"id":"2535026804","title":"Target Corp. : Oppenheimer Cuts Target Price to $130 From $150","url":"https://stock-news.laohu8.com/highlight/detail?id=2535026804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535026804?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:06","pubTimestamp":1747224405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nAZN3TYK7Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4597","LU1244550577.SGD","LU0310799852.SGD","BK4596","LU0310800965.SGD","LU2237443622.USD","BK4504","LU0823411888.USD","LU0211328371.USD","LU2237443382.USD","BK4532","BK4155","LU0128525689.USD","BK4588","LU0052756011.USD","LU1244550494.USD","LU2237443978.SGD","LU0211327993.USD","BK4585","LU1244550221.USD","LU1267930490.SGD","LU2237443549.SGD","BK4114","LU1267930227.SGD","TGT","BK4533"],"gpt_icon":0},{"id":"2535360025","title":"Incyte Corp - to Pay Novartis $280 Mln in Royalty Settlement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2535360025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535360025?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:54","pubTimestamp":1747223695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1UZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","BK4588","BK4585","BK4550","INCY"],"gpt_icon":0},{"id":"2535025353","title":"Incyte: on May 11, Co & Novartis Entered Into Settlement Agreement With Respect to Litigation Initiated by Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025353","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025353?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:54","pubTimestamp":1747223695,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","INCY","BK4588","BK4585","BK4550"],"gpt_icon":0},{"id":"2535253200","title":"Incyte Corporation Settles Royalty Dispute with Novartis, Agrees to $280 Million Payment and Reduced Future Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2535253200","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535253200?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:54","pubTimestamp":1747223649,"startTime":"0","endTime":"0","summary":"Incyte Corporation has announced a significant development in its business relationship with Novartis Pharma AG. On May 11, 2025, the two companies reached a settlement agreement concerning a dispute over royalty payments related to the drug JAKAFI. Under the terms of the agreement, Incyte will pay Novartis $280 million to settle disputed royalties on U.S. sales of JAKAFI through December 31, 2024. Additionally, the royalty rate on future net sales of JAKAFI in the United States will be reduced by 50% starting January 1, 2025, for a period specified in the Settlement Agreement. This adjustment will result in a reduced royalty payment of approximately $14.9 million for the quarter ending March 31, 2025. The financial implications of this settlement will be reflected in Incyte's financial statements for the quarter ending June 30, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDLbxCPVw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4532","BK4550","BK4588","INCY"],"gpt_icon":0},{"id":"2535023776","title":"BRIEF-Pony AI Announces Voluntary Extended Lock-Ups By Founders","url":"https://stock-news.laohu8.com/highlight/detail?id=2535023776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535023776?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:49","pubTimestamp":1747223366,"startTime":"0","endTime":"0","summary":"BRIEF-Pony AI Announces Voluntary Extended Lock-Ups By FoundersMay 14 (Reuters) - Pony AI Inc PONY.O:PONY AI INC. ANNOUNCES VOLUNTARY EXTENDED LOCK-UPS BY FOUNDERSSource text: ID:nGNX7SdQmMFurther company coverage: PONY.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA1RQZHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","IE00B7SZLL34.SGD","BK4559","IE00BFSS8Q28.SGD","IE00BFSS7M15.SGD","LU0320765489.SGD","IE00B19Z3581.USD","BK4585","IE00BJJMRY28.SGD","IE0002270589.USD","LU1074936037.SGD","LU0061475181.USD","IE00B7KXQ091.USD","BK4023","IE0004445015.USD","BK4532","IE00B19Z3B42.SGD","PONY","LU2133065610.SGD","IE00BJJMRX11.SGD","LU0208291251.USD","LU0149725797.USD","LU0320765646.SGD","LU1162221912.USD","LU1585245621.USD","LU2237438978.USD","BK4131","BK4550","UPS","LU0070302665.USD","LU1430594728.SGD","BK4588","BK4534"],"gpt_icon":0},{"id":"2535127023","title":"Global-e, Shopify Extend Strategic Partnership With New Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2535127023","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535127023?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:45","pubTimestamp":1747223130,"startTime":"0","endTime":"0","summary":"Global-e Online  said Wednesday it has entered into a three-year agreement with Shopify  to renew their strategic partnership.The partnership covers first-party and third-party services, namely the Shopify Managed Markets and Merchant of Record services, Global-e said.Under the agreement, Global-e said it will remain the exclusive provider of merchant-of-record services for Shopify Managed Markets.The new agreement will allow for additional merchant-of-record providers to work with Shopify merchants, although Global-e will remain the \"preferred partner\" and enjoy exclusive access to key features and enhanced commercial terms, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5e7dab792d976df877606e9dc7eb0c38","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4524","LU0823421416.USD","BK4566","BK4220","LU1804176565.USD","SHOP","BK4613","LU1720051017.SGD","BK4532","BK4551","BK4116","LU1548497426.USD","GLBE","BK4539","LU1861559042.SGD","BK4588","LU0823421333.USD","LU2265009873.SGD","BK4548","LU2357305700.SGD","LU1720051108.HKD","LU1861558580.USD","LU0390134368.USD","BK4528","BK4585","BK4122"],"gpt_icon":1},{"id":"2535023701","title":"Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?","url":"https://stock-news.laohu8.com/highlight/detail?id=2535023701","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535023701?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:45","pubTimestamp":1747223100,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics has an approved gene-therapy treatment still in its early growth stages.The company isn't profitable, but has a strong cash position, which can help buy a lot of time.One of the biggest opportunities in healthcare today centers around genome editing. According to analysts at Grand View Research, the global genome market is expected to expand at a compound annual growth rate of more than 16% until the end of the decade. Stocks involved in gene-editing therapies could be incredible investments to hold on to in the long run. One of them is CRISPR Therapeutics . It has an approved gene-editing therapy, but investors haven't been buying up the stock. Instead, it's been in a free fall over the past year. Its financials haven't been looking all that impressive and as a result, growth investors have been dumping the stock. But could that be a mistake?Image source: Getty Images.Is a lack of profitability keeping investors away?Entering trading this week, shares of CRISPR are","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/14/are-investors-making-a-big-mistake-dumping-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0823416689.USD","IE00B894F039.SGD","LU1069344957.HKD","IE00B19Z9Z06.USD","LU2237438978.USD","LU0109394709.USD","SG9999001176.USD","LU2236285917.USD","CRSP","BK4007","LU2324357040.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","IE0009355771.USD","BK4611","LU2362540622.SGD","BK4532","VRTX","LU1861558580.USD","BK4023","BK4585","LENZ","LU1430594728.SGD","LU0289739699.SGD","LU0757428866.USD","LU1861559042.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","BK4588","BK4211","LU2362541273.HKD","IE00BJJMRZ35.SGD","ISBC","LU0058720904.USD","LU1585245621.USD","LU2462157665.USD","IE00B2B36J28.USD","LU0320765992.SGD","LU1093756168.USD","BK4139","SGXZ57979304.SGD","LU0234570918.USD","VERX","LU0417517546.SGD","BK4567","LU2417539215.USD","IE0002141913.USD","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2535028025","title":"Novo Nordisk, Septerna to Collaborate on Oral Small Molecule Obesity Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2535028025","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535028025?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:39","pubTimestamp":1747222788,"startTime":"0","endTime":"0","summary":"Novo Nordisk  and Septerna  said Wednesday they will collaborate on a project to develop and commercialize oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases.Under the terms of the agreement, Septerna is eligible to receive about $2.2 billion from Novo Nordisk for upfront payments and research, development and commercial milestone payments, the companies said.Septerna shares jumped 63% in premarket trading, while Novo Nordisk was 2.2% higher.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7104","LU0154236417.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","SEPN","LU1093756168.USD","NVO","BK4007","BK4599","NVO.AU","LU1093756325.SGD","IE00BKVL7J92.USD","BK4585","MDCO"],"gpt_icon":1},{"id":"2535023869","title":"Zoom 1Q Loss Y181.00M Vs Loss Y78.00M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535023869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535023869?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:39","pubTimestamp":1747222740,"startTime":"0","endTime":"0","summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4023","BK4548","BK4554","BK4613","ZM","BK4528","BK4505","BK4551","BK4525","BK4588","BK4535","BK4585","LU1861559042.SGD","LU1861558580.USD"],"gpt_icon":0},{"id":"2535028639","title":"Pony AI Inc. Announces Voluntary Extended Lock-Ups by Founders","url":"https://stock-news.laohu8.com/highlight/detail?id=2535028639","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535028639?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:30","pubTimestamp":1747222254,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA1RQZHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU1585245621.USD","LU0320765489.SGD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","IE0004445015.USD","BK4532","BK4585","IE0002270589.USD","LU1074936037.SGD","LU1162221912.USD","BK4131","IE00B19Z3581.USD","LU0320765646.SGD","IE00BJJMRX11.SGD","IE00BFSS8Q28.SGD","LU1430594728.SGD","LU0208291251.USD","LU2237438978.USD","IE00BJJMRY28.SGD","BK4550","UPS","PONY","BK4534","LU0211331839.USD","LU2133065610.SGD","IE00B7KXQ091.USD","LU0061475181.USD","LU0149725797.USD","BK4559","IE00BFSS7M15.SGD","LU0070302665.USD","BK4023"],"gpt_icon":0},{"id":"2535040252","title":"Novo Nordisk, Septerna to Partner on Oral Small Molecule Obesity Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2535040252","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535040252?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:24","pubTimestamp":1747221879,"startTime":"0","endTime":"0","summary":"Novo Nordisk, Septerna to Partner on Oral Small Molecule Obesity Medicine","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","IE00BKVL7J92.USD","LU0154236417.USD","SEPN","IE00BZ1G4Q59.USD","BK4599","BK4007","BK4585","BK4588","LU1093756168.USD","NVO","LU1093756325.SGD"],"gpt_icon":0},{"id":"2535338047","title":"Exelixis Inc : Stifel Raises Target Price to $38 From $36","url":"https://stock-news.laohu8.com/highlight/detail?id=2535338047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535338047?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:07","pubTimestamp":1747220858,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4532","EXEL"],"gpt_icon":0}],"pageSize":20,"totalPage":60,"pageCount":16,"totalSize":1190,"code":"91000000","status":"200"}]}}